Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Primary Biliary Cirrhosis
91%
Primary Sclerosing Cholangitis
33%
Autoimmune Hepatitis
32%
Sclerosing Cholangitis
28%
Immunoglobulin G4
27%
Ursodeoxycholic Acid
26%
Diseases
25%
Liver Cirrhosis
25%
Liver Transplantation
20%
Cholangitis
16%
Hepatocellular Carcinoma
16%
Liver Disease
15%
Liver Injury
15%
Hazard Ratio
14%
Toxic Hepatitis
13%
Bleeding
12%
Acute on Chronic Liver Failure
12%
Direct Oral Anticoagulant
11%
Atrial Fibrillation
11%
Bezafibrate
10%
Gastrointestinal Bleeding
9%
Long-Term Outcome
9%
Clinical Feature
9%
Hepatitis C Virus
8%
Cholestasis
8%
Odds Ratio
8%
Fibrosis
8%
Prevalence
8%
Recurrent Disease
8%
Chronic Liver Disease
8%
Quality of Life
8%
Autoantibody
8%
Disease Course
8%
Bile Duct
8%
Acute Liver Failure
7%
Pediatrics
7%
Hepatology
7%
Autoimmune Pancreatitis
7%
Cholangiocarcinoma
6%
Liver Failure
6%
Prognostic Factor
6%
Bilirubin
6%
Cohort Analysis
6%
Bile Duct Stone
6%
Etiology
6%
Pruritus
6%
Anti-Mitochondrial Antibody
6%
Albumin
5%
Hepatocyte
5%
Placebo
5%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Biliary Cirrhosis
67%
Autoimmune Hepatitis
35%
Primary Sclerosing Cholangitis
27%
Ursodeoxycholic Acid
22%
Diseases
16%
Liver Injury
15%
Chronic Hepatitis C
15%
Hepatitis C Virus
14%
Bile Acid
14%
Liver Cirrhosis
14%
Liver Cell Carcinoma
11%
Ribavirin
11%
Acute on Chronic Liver Failure
11%
Liver Disease
10%
Toxic Hepatitis
10%
Cholangitis
10%
Pruritus
9%
Autoimmune Liver Disease
9%
Bezafibrate
9%
Direct Oral Anticoagulant
8%
Atrial Fibrillation
8%
Prevalence
8%
Bleeding
8%
Combination Therapy
7%
Placebo
7%
Hepatitis C
7%
Chronic Liver Disease
7%
Gastrointestinal Hemorrhage
7%
Autoantibody
6%
Interferon
6%
Immune Checkpoint Inhibitor
6%
Syndrome
5%
Peginterferon
5%
Adverse Event
5%
Immunoglobulin G4
5%
Fibrosis
5%
Recurrent Disease
5%
Liver Fibrosis
5%
Antiviral Therapy
5%
Antiviral Drug
5%
Immunology and Microbiology
Primary Biliary Cirrhosis
100%
Autoimmune Hepatitis
48%
Primary Sclerosing Cholangitis
31%
Autoantibody
20%
Anti-Mitochondrial Antibody
19%
Liver Transplantation
15%
Immunoglobulin G4
14%
Autoimmune Liver Disease
11%
Susceptibility
10%
Single Nucleotide Polymorphism
9%
Genome-Wide Association Study
8%
Autoimmune Disease
7%
Autoantigen
7%
Prevalence
7%
Hepatitis C Virus
6%
Hepatitis
5%
Enzyme-Linked Immunosorbent Assay
5%
Pyruvate Dehydrogenase
5%
Bile
5%